Familial Alzheimer's disease-linked variants of presenilin (PSEN1 and PSEN2) contribute to the pathophysiology of disease by both gain-of-function and loss-of-function mechanisms. Here, PSEN2 is linked to early-onset autosomal dominant Alzheimer disease.